Burning Rock Biotech Ltd
For the period ended Sep 8, 2025. Filed Sep 8, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Sep 8, 2025 · Filed Sep 8, 2025
Use the contents to explore the available documents and sections.
BNR$13.42+1.3%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Selected Operating Data
Selected Operating Data
| As of | |||||
|---|---|---|---|---|---|
| June 30,2024 | September 30,2024 | December 31,2024 | March 31,2025 | June 30,2025 | |
| In-hospital Channel: | |||||
| Pipeline partner hospitals(1) | 29 | 30 | 29 | 30 | 30 |
| Contracted partner hospitals(2) | 59 | 61 | 63 | 63 | 63 |
| Total number of partner hospitals | 88 | 91 | 92 | 93 | 93 |
| (1) | Refers to hospitals that are in the process of establishing in-hospital laboratories, laboratory equipment procurement or installation, staff training or pilot testing using the Company’s products. |
| (2) | Refers to hospitals that have entered into contracts to purchase the Company’s products for use on a recurring basis in their respective in-hospital laboratories the Company helped them establish. Kit revenue is generated from contracted hospitals. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.